TTP Labtech

[WHITEPAPER] Multiplexed fluorescence ELISA assays on mirrorball®

Multiplexed fluorescence ELISA assays on mirrorball® Download the whitepaper courtesy of TTP Labtech Inc here > Enzyme-linked immunosorbant assays (ELISA) can be used in multiple stages of the drug discovery process to help identify and measure the cellular responses to therapeutic or toxic molecules. The most common ELISA format is the sandwich assay. Briefly, a capture antibody is immobilised onto …

Andrew Hiatt of Mapp's 2015 Presentation

Mapp shares lessons learned from Ebola

We were excited to have Andrew Hiatt, CSO of Mapp, gave a keynote address titled “Lessons from Ebola – Pandemic preparedness and antibodies against infectious diseases” at last year’s Americas Antibody Congress. Download his presentation now > You can now download his presentation to find out more about: Typical symptoms of the Ebola virus disease Emerging treatments Antibody failures Neutralization …

Preview agenda announcement - Americas Antibody Congress

Announcing the release of the preview agenda – Americas Antibody Congress

The preview agenda for Americas Antibody Congress 2016 is now LIVE. Download the preview agenda here > Join us in San Diego next May for an expanded two-day event and deeper content than ever before in: Antibody Engineering Oncology Infectious Diseases ADCs/Bioconjugates Download the preview agenda here to find out more about the content on offer > That’s four full …

Industry Insights: European Antibody Congress 2015

The past year has been hugely defining in the discovery and development of therapeutics antibodies. From huge advances in cancer therapies and immune system modulation to recent developments in immunotherapy, neurological applications, treating infectious disease to creating vaccines: antibody based drugs are set to have profound effects in every area of medicine in the very near future. Covering everything from …

Rapid Eradication of a Bulky Melanoma Mass with One Dose of Immunotherapy

Combination Immunotherapy Significantly More Effective than Ipilimumab Alone for Patients with Advanced Melanoma

Researchers from Memorial Sloan Kettering Cancer Center (MSK) are reporting exciting results in the field of cancer immunology. Positive results from a clinical trial published recently in The New England Journal of Medicine show that the combination of the immunotherapy drugs ipilimumab (Yervoy™) and nivolumab (Opdivo™), produced significantly better outcomes than ipilimumab alone in patients with advanced melanoma. A second …

Antibiotics crisis – will PPPs solve the need for super drugs?

[pullquote type=”right”]“[AMR] is an increasingly serious threat to global public health that requires action across all government sectors and society.” – World Health Organization[/pullquote] It is an alarming fact that AMR (AntiMicrobial Resistance) claims 23,000 Americans lives each year. According to a report commissioned by British Prime Minister David Cameron, AMR could result in 10 million deaths a year by …

Singapore’s first FDA approval for novel drug

MerLion Pharmaceuticals, a joint venture between the Institute of Molecular and Cell Biology (IMCB) and GlaxoSmithKline, received the first FDA approval for a novel drug amongst the outstanding biotechs based in Singapore. MerLion’s finafloxacin was acquired after its merger withCombinature Biopharm AG and Athelas SA in 2006, and is targeted for acute otitis externa (also known as “swimmer’s ear”). Thanks …

BioPharma México es donde reunen los expertos de la industria biofarmacéutica mexicana para relacionarse, aprender, y discutir los desarrollos más recientes de las células madre.

Portable, disposable, rapid dengue diagnostic

Singapore’s Agency for Science, Technology and Research (A*STAR) has created a diagnostic kit for near-instant detection of dengue infection. This early detection method adopts dengue antibody and nanotechnologies to cope with the infamous tropical disease within the region. Click here to find out more. Vaccines and medical devices are handy tools in preventing the development of syndromes upon infections. BioPharma Asia Convention …

Roche, Meiji & Fedora next in line to combat superbugs with antibiotics booster

Roche makes its next move in antibiotic research with its licensing deal with Meiji Seika Pharma and Canada’s Fedora. The deal, worth up to $750 million, allows Roche the right to develop and commercialize beta-lactamase inhibitor OP0595 internationally, with exception to Japan. Meiji gets to keep its sole rights. Beta-lactamase inhibitors restore or potentiate the activity of beta-lactam antibiotics. The …

Download White Paper – Fed-Batch Cell Culture Process Development

CHO cell lines usually adopt the Fed-Batch approach as a primary method to manufacture therapeutic recombinant protein products. Process development for this method has been usually on how best to support high-cell density cultures that are necessary to achieve high product titres production. The issue however has always been the high nutritional demands required. If there is a lack of …